Retatrutide 10mg

Retatrutide represents the leading edge of metabolic research as a "triple agonist" peptide. This 10mg formulation is utilized in laboratory settings to investigate the simultaneous activation of the GLP-1, GIP, and glucagon receptors. Researchers use this compound to study the complex interplay between insulin secretion, gastric emptying, and energy expenditure, providing a comprehensive view of triple-pathway metabolic regulation.